NewAmsterdam Pharma Company N.V. (NAMS)

SEC filing

NewAmsterdam Pharma Company N.V.

NAMS · CIK 1936258

4 · Jan 29, 2026 · Kooij Louise Frederika sold 72.43K shares at $32.25/share ($2.3M); exercised options for 72.43K shares

Kooij Louise Frederika sold 72.43K shares at $32.25/share ($2.3M); exercised options for 72.43K shares

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).